Search results
Allan Camaisa co-founded Calidi Biotherapeutics in 2014 and has served as CEO and Chairman of the Board since 2018. He was an early investor in Calidi, and determined to bring a cure for difficult-to-treat cancers to market after losing his own father to cancer.
Allan Camaisa is a serial entrepreneur, investor, and technologist, with proven…. · Experience: Calidi Biotherapeutics · Education: Harvard Business School · Location: San Diego · 500 ...
Pioneering Progress. CEO of Calidi Biotherapeutics, Allan Camaisa, Visits Sully on Set of Big Biz TV to Discuss Recent Benchmarks in Advancing Pipeline for Cancer Cure. A talented, seasoned group of world-class executives, doctors, and scientists producing revolutionary work. Learn more.
Allan Camaisa serves as Chairman of the Board of Directors and has been the CEO of Calidi Biotherapeutics since November 2017. Allan was an early investor in Calidi, and determined to bring a cure for difficult-to-treat cancers to market after losing his own father to cancer.
An Interview with Allan Camaisa, Calidi Biotherapeutics CEO: “We are Disrupting Traditional Cancer Treatments.” The Silicon Review “Our mission is to eradicate difficult-to-treat cancers, through enhanced oncolytic viruses potentiated and delivered by stem cells which is a breakthrough for cancer patients.”
Allan Camaisa is a serial entrepreneur, investor, and technologist, with proven leadership skills in bootstrapping start-ups. He has had four successful exits, which were sold to publicly traded Fortune 1000 companies with tremendous shareholder returns.
Allan Camaisa is Chairman/CEO at Calidi Biotherapeutics Inc. See Allan Camaisa's compensation, career history, education, & memberships.
